stimulated cells CCL24 protein was below detection limit. Most polyps comprised signifi cant amounts of CCL24 (mean 0.24 ng/mg). TNF-␣ , INF-␥ or IL-4 induced CCL24 protein (0.1-0.3 ng/ml) in epithelial cells. Costimulation with TNF-␣ and IL-4 (0.1-30 and 1-30 ng/ml, respectively) synergistically induced synthesis of CCL24 protein (0.18-0.31 ng/ml). Conclusion: In nasal polyps endothelial and epithelial cells are obviously the main source of CCL24, which was shown for transcription (mRNA) and production (protein) levels and was associated with diseases. Results gave evidence of CLL24-directed migration of cells from inside (the bloodstream) to the epithelial side (mucosa) in eosinophilic infl ammatory diseases, e.g. nasal polyposis.
(up to 25%) and intrinsic asthma (up to 40%). The triad of nasal polyposis, asthma, and aspirin intolerance is known as 'Widal syndrome' [2] . Nasal polyps are characterized histologically by edema, fi brosis, decreased vascularization, and diminished glands [1] [2] [3] [4] .
The pathogenic explanation of eosinophilia in nasal polypous tissue focused on an increased transendothelial migration and inhibition of apoptosis in eosinophilic granulocytes [5, 6] . Nevertheless, the pathogenesis of chronic polyposis in sinusitis is still unknown. Intolerance to nonsteroidal anti-infl ammatory drugs (NSAIDs), chronic infection, epithelial disruption, epithelial cell defects, and inhalation/food-associated allergies are known to be associated with nasal polyps [6, 7] . Tos [8] proposed increased edema of submucosal tissue with rupture of the epithelial layer, prolapse into the sinus which is followed by reepithelization as a model of polyp development. Histomorphologically eosinophils are present in early stage manifestations of nasal polyps, forming a subepithelial cap over a pseudocyst area that was fi lled with albumin [9] . Eosinophils, in turn, are attracted and activated by chemokines. Activity of eosinophils is positively correlated to the concentration of chemokines and the number of activated eosinophils correlates directly with nasal polyp formation [10] . An increased expression and production of a variety of proinfl ammatory cytokines in nasal polyps were reported and are assumed to contribute to the chronic eosinophilic infl ammation-regulating migration, survival, and activation of eosinophilic granulocytes.
Chemokines are known to have leukocyte subtype-selective properties in vitro. Among the four classes of chemokines CXC, CC, C, and CX 3 C -classifi ed by the conserved cysteine residues of immature proteins -the CC chemokines RANTES, eotaxin (CCL11), and eotaxin-2 (CCL24) attract eosinophils in vitro. Therefore, these chemokines are major candidates of eosinophilic infi ltration [11, 12] . Recently detected CCL24 induces chemotaxis of eosinophilic as well as basophilic granulocytes [13, 14] . Despite minor structural homologies of CCL11 and CCL24, both chemokines exclusively use the CCR-3 receptor and show the same effi ciency in selective chemoattraction of eosinophils, but a higher potency for CCL11 [13] . The expression of CCL11 mRNA is increased in nasal polyps of atopic and nonatopic patients [15] . Similar results were obtained in bronchial biopsies from atopic and nonatopic asthmatics [16] . As shown by our group and others cultured human nasal fi broblasts and epithelial cells express CCL11 mRNA, whereas mRNA of CCL24 was not expressed [15] [16] [17] . Infection by rhinovirus upregulated neither the expression of mRNA of CCL11 nor of CCL24 in bronchial epithelial cells [18, 19] .
The aim of this study was to localize the cellular source, to analyze the basal as well as modulated mRNA expression. The production of CCL24 was quantifi ed in unaffected human nasal mucosa as well as nasal polyps. These results obtained from native human nasal tissue in vivo were compared to those revealed from cultured human fi broblasts and epithelial cells to clarify the role of CCL24 in eosinophilic polyposis.
Patients and Methods

Patients
Specimens from 40 patients, 12 females (aged 18-70, mean 48) and 28 males (aged 10-74, mean 53) were investigated. Nine individuals served as controls (4 females, aged 20-73, mean 43; 5 males, aged 23-64, mean 49). Controls received treatment for noninfl ammatory diseases, such as deviation of the septum. Individuals of the control group had no signs of allergic symptoms, chronic or recurrent polyposis, asthma bronchiale, or other chronic diseases, inconspicuous CT scan and endoscopic investigation.
Thirty-one patients (16 females, aged 18-68, mean 45; 15 males, 26-74, mean 52) served as polyp group suffering from sinusitis accompanied with chronic nasal polyposis, which was diagnosed by patient history, endoscopic investigation, and CT scan. Nineteen patients suffered from allergic rhinitis (10 females, aged 12-65, mean 43; 9 males, aged 16-68, mean 51), diagnosed by patient history, and additionally by prick testing. Nine patients (4 females, aged 10-60, mean 48; 5 males, aged 23-74, mean 51) suffered from intrinsic asthma. Intolerance to NSAIDs was diagnosed in 3 patients (2 females, aged 36 and 42; 1 male, aged 45). All asthmatic patients used inhalational ß-sympathomimetics as regular medication, 3 of them used inhalational corticoids (budenoside 0.2 mg/day b.i.d.) as an additional drug.
Patients of both control and nasal polyp group received neither systemic corticosteroids nor other immune-modulating drugs.
Sampling of Tissue Specimens
Tissue specimens were taken from the anterior part of the inferior turbinate (control group) or the middle meatus (polyp group). Specimens were obtained during endoscopic surgery of the sinus, immediately frozen in liquid nitrogen, and stored at -80 ° C until further processing.
The patients included had visible polyps at the endoscopic endonasal investigation and a Lund-Mackay score (CT scans) of more than 14. Eosinophils in the tissue were shown histopathopysiologically by hematoxylin-eosin staining using high power fi eld investigation counting more than 100 eosinophils per high power fi eld in each polyp. Five high power fi elds for each specimen were investigated, which was independently verifi ed at the Department of Pathology, University of Kiel, and the arithmetic mean was documented.
Cytokines, Antibodies, and Other Reagents
Recombinant human CCL24, TNF-␣ , INF-␥ , and IL-4 were purchased from R&D Systems (Wiesbaden, Germany), peroxidase blocking reagent and 3-amino-9-ethylcarbazole (ACE) as chromogenic substrate from DAKO (DAKO Diagnostics, Hamburg, Germany), and o -phenylenediamine dihydrochloride (OPD) from Sigma (Deisenhofen, Germany). The antibodies used for this investigation were the following: polyclonal goat anti-human CCL24 (Natutec, Frankfurt, Germany), as well as a biotinylated rabbit anti-goat polyclonal antibody (Amersham, Braunschweig, Germany) for immunohistochemistry. Mouse IgG (Sigma) was used as negative control; polyclonal rat anti-CCL24 antibody (R&D Systems), monoclonal mouse anti-human CCL24 clone 2D5/G6 and 1D2/A12 (Department of Dermatology, University of Kiel, Germany), and peroxidase-conjugated rabbit anti-mouse (Jackson Immunoresearch Lab., West Grove, Pa., USA) were used for enzyme immunoassay. Primer of GAPDH and CCL24 were synthesized and purchase from MWG Biotech (Munich, Germany). The following primers were used: GAPDH forward primer 5 -CCA GCC GAG CCA CAT CGC-3 , GAPDH reverse primer 5 -ATG AGC CCA GCC TTC ACC AT-3 (360-bp product); CCL24 forward primer 5 -CTA CCG GCT CTG TGG TC-3 , CCL24 reverse primer 5 -GGT TTG GTT GCC AGG ATA-3 (290-bp product). Culture medium MEM and DMEM was obtained from PromoCell (Heidelberg, Germany). Chemicals for buffers were purchased from Merck (Darmstadt, Germany).
CCL24 Immunhistochemistry
Routine semithin sections (5 m) were prepared from inferior turbinate and polypous tissue specimens stored in liquid nitrogen. Immunohistochemistry was performed as follows: samples were thawed [overnight, room temperature (RT)], air dried, and washed 3 times using PBS (pH 7.5, RT). Peroxidase blocking reagent was added (20 min, RT) followed by a washing step and blocking of unspecifi c binding sites by addition of diluted normal serum (1: 100 in PBS, 30 min, RT). Subsequently goat anti-CCL24 antibody was added (0.25 g/ml, overnight, 4 ° C). Following additional washing, sections were incubated with a secondary biotinylated antigoat antibody (1: 100 in PBS, 45 min, RT). Then ACE substrate solution was added (1: 100 diluted in substrate buffer, 15 min, RT; according to the instructions of the manufacturer). Followed by a fi nal washing step, specimens were counterstained with hematoxylineosin (10 s, RT), rinsed in H 2 O (1 min, RT) and analyzed microscopically.
Cell Culture
For cell culture experiments the human bronchial tumor epithelial cell line A-549 was selected as a well-established representative human respiratory epithelial cell line. Furthermore, the hypothesis of the importance of chemokines in respiratory cells is well established in either bronchial or nasal infl ammatory diseases, correlating with the eosinophilic infi ltration in the respiratory mucosa. Therefore, A-549 cells were tested in former experiments by our group showing no differences to primary nasal cells concerning the chemokine expression. In addition, A-549 cells were selected as a relevant model cell line revealing reproducibility of in vitro experiments. A-549 was purchased form CLS (Heidelberg, Germany) and cultured under standard conditions in DMEM. Cellular viability were controlled by morphological criteria. Experiments were performed on subcultures between the third and seventh passage.
Fibroblast culture was performed as negative control experiments based on former results [17] . Nasal fi broblasts of inferior turbinates were obtained by standard enzymatic digestion as published previously [20] with minor modifi cations. Briefl y, biopsy specimens were collected in MEM-containing gentamycin (50 mg/ ml). Specimens were digested overnight at 4 ° C using trypsin solution (0.17%). Digestion was stopped by adding MEM containing 10% FCS. Cells were pelleted (7 min, 400 g , RT), resuspended in 10% FCS-conditioned MEM, and seeded in polystyrene culture dishes at a density of 5 ! 10 5 cells. Cells were cultured under standard conditions (37 ° C, 5% CO 2 , humidifi ed air). Medium was changed every second day.
Basal expression of CCL24 mRNA and CCL24 production in A-549 cells and nasal fi broblasts were analyzed from cells cultured in medium without any additives. The effects of various proinfl ammatory cytokines were analyzed upon 24 h of exposure to TNF-␣ (1-50 ng/ml), IFN-␥ (1-300 U/ml), IL-4 (0.1-50 ng/ml), or a combination of TNF-␣ (0.1-30 ng/ml), IFN-␥ (3-30 U/ml), and IL-4
(1-30 ng/ml) as indicated. Exposure to cytokines was done by exchange of culture media with or without the relevant concentration of cytokines.
Semiquantitative Reverse Transcriptase Polymerase Chain Reaction
Semiquantitative reverse transcriptase polymerase chain reaction (SQRT-PCR) was performed as described previously with minor modifi cations [21] . In brief, total RNA of nasal polypous specimens was isolated according to the protocol of Chomcynski and Sacchi [22] . RNA was quantifi ed photometrically at 260 and 280 nm. The quality of isolated RNA was assured by both quantifying absorption ratio at 260/280 nm and verifying RNA in an 1% agarose gel. A photometric ratio of 1.7 to 2.0 in combination with two clear bands on the gel of the tested were used as criteria for selecting RNA for further processing. cDNA was amplifi ed from 1 g of total RNA by reveres transcriptase, followed by polymerase chain reaction using specifi c primers for CCL24 and GAPDH. Reaction mixture was preheated at 95 ° C for 1 min, 67 ° C for 1 min and 72 ° C for 2 min, followed by an amplifi cation of the targets using 31 cycles with denaturation at 95 ° C for 45 s and annealing at 60 ° C for 1 min. mRNA expression of GAPDH served as internal standard. The reaction product was separated in a 2% agarose gel and visualized by ethidium bromide under UV light. Gels were digitally scanned for computer-assisted data processing. The intensity of bands was densitometrically quantifi ed using the software package Biometra BioDoc II. CCL24-specifi c bands were normalized to GAPDH. Results were given as percent relative (rel.) density.
Primer specifi city was verifi ed by extraction of CCL24 from the gel and by specifying the nucleotide sequence using the 310 Gentic Analyzer of Perkin Elmer (Weiterstadt, Germany). Data were compared to data from the gene bank of PubMed.
CCL24 ELISA
Concentration of CCL24 protein production was determined in duplicates by a sandwich enzyme-linked immunosorbent assay (ELISA). Therefore, samples were prepared from 200 mg of homogenized (1 min on ice by ultrasound) nasal polypous tissue specimens or of the nasal inferior turbinates frozen by liquid nitrogen and thereafter dissolved in citrate buffer (2 ml, pH 2.5). Followed by centrifugation and lyophilization, phosphate buffer (pH 7.0) was added, and solution was stored at -70 ° C until further processing.
As published recently [21] , 96-well microtiter plates (Sarstedt, Nümbrecht, Germany) were coated with polyclonal anti-CCL24 IgG (1 g/ml, overnight, 4 ° C) dissolved in coating buffer (0.1 M Na 2 CO 3 , 0.2 M NaHCO 3 , pH 10.5). Unspecifi c binding sites were blocked by addition of PBS-BSA (1% w/v, 1 h, RT). Subsequently, samples or standards of recombinant CCL24 and secondary mouse anti-CCL24 antibody (0.5 g/ml) were added (100 l/well, each) and incubated (90 min, RT), followed by incubation with peroxidase-labeled anti-mouse Ig (20 min, RT). Finally OPD substrate solution was added (100 l/well, 25 min, RT) and reaction was stopped by adding of 3 M H 2 SO 4 (100 l/well). Each incubation step was followed 3 times by a washing step using PBS-Tween (5% v/v). Standard was analyzed in duplicates at seven concentration levels (9-5,000 pg/well). Optical density was measured at 492 nm using the MR-5000 microplate reader (Dynatech Laboratories, Denkendorf, Germany). Concentrations of samples were calculated by a computerized calibration cubic spline curve. Results obtained were normalized to the protein content of the relevant sample. They were expressed as arithmetic mean of duplicate measurements in ng/mg polypous tissue. The interassay variance was 14.3%, the intra-assay variance was 6.8%, calculated from 12 experiments performed in preliminary experiments before applying the assay for quantifi cation of the samples.
Statistical Analyses
Densitometry analysis was performed using the software package Biometra BioDoc II. All data are expressed as mean 8 SEM. Signifi cance was determined using Student's t test for comparison of two means. Means were considered signifi cant (p ! 0.05) or highly different (p ! 0.01). Results of CCL24 mRNA expression and CCL24 synthesis were calculated as arithmetic mean of duplicate measurements. For respective conditions 3 up to 7 replicates from controls or patients were analyzed. Normal distribution of the control measurements could be assumed by the KS test.
Due to the small number of samples and the partially higher variation of the values of CCL24 mRNA or protein synthesis statistical tests could not be applied for all samples. Wherever applicable data were expressed as mean 8 SEM. Results of respective measurements were presented as dots, and the arithmetic means were represented as horizontal lines, which was evaluated by the average value from the measurements plus 2 standard deviations (Institute of Statistical Analyses, University of Kiel, Germany).
Results
CCL24 Localization in Tissue Samples
The inferior nasal turbinate obtained from 9 patients of the control group were negatively immunohistochemically stained for CCL24 ( fi g. 1 a) concerning epithelial, endothelial, connective, or glandular cells. In contrast, 96% of nasal polypous tissue specimens (30 out of 31 patients suffering from nasal polyposis accompanied by eosinophilia) showed immunohistochemically signifi cantly (p = 0.05, compared to controls) positive CCL24 staining of epithelial and endothelial cells (up to 87 and 79%, respectively), without achieving a statistically signifi cant difference comparing these cell types. Only the specimen of 1 patient, suffering from chronic polyposis with intrinsic asthma, was negative for immunoreactive staining of CCL24. Connective tissue cells and glandular cells were immunohistochemically negative for in the polyp group ( fi g. 1 b). The semiquantitative evaluation of eosinophil count in polypous specimens revealed negative results in the control group (i.e. 0-2% eosinophils per high power fi eld), whereas the polyp group was characterized by intermediate to severe eosinophil counts (i.e. ϳ 50-74% per high power fi eld); in more detail there were severe eosinophils (53-74%) in allergic rhinitis, intermediate eosinophils (42-61%) in asthmatics, and low eosinophils (28-43%) in patients intolerant to NSAIDs. There was a fl imsy correlation (R = 0.73) of CCL24 protein expression and eosinophil counts in polypous tissue specimens.
Expression of CCL24 mRNA in Nasal Tissue
All 40 specimens analyzed expressed CCL24 mRNA. Representative results of two controls and eight polypous tissue samples are presented in fi gure 2 . The upper band (318-bp product) represents GAPDH expression and shows equal loading. The lower band (290-bp product) represents CCL24 mRNA. In polypous tissue CCL24 mRNA expression varied between 0.7 and 24.3% (mean 4.2%, median 3.6%), which was signifi cantly higher (p ! 0.05) than in controls [range ! 0.3 to 1.7% (mean 0.69%, median 0.78%)]. Two representative results of controls (0.9 and 1.4% rel. density; lanes 3 and 12, respectively) and 7 patients suffering from chronic polypous sinusitis (2.6-24.3% rel. density; fi g. 2 , lanes 3-11, respectively) are shown in fi gure 2 . The densitometric results of all experiments are summarized in fi gure 3 .
Expression of CCL24 mRNA of polypous tissue did not differ statistically signifi cantly between patient groups suffering from of bronchial asthma (mean 4.1, median 3.9, range 0.9-22.1), aspirin intolerance (mean 3.8, median 3.2, range 0.7-24.3), and nasal polyposis (mean 4.3, median 4.0, range 0.8-23.7), due to the small number of samples investigated.
Synthesis of CCL24 in Nasal Tissue
The production of CCL24 protein was quantifi ed in 7 out of 9 (77%) controls and in 23 out of 31 (74%) nasal polyps. The amount of CCL24 in controls was below the validated detection limit of the assay ( ! 0.01 ng/ml). Nasal polyps produced signifi cantly more CCL24 (median: 0.24 ng/mg; range: 0.05 up to 0.43 ng/mg; p ! 0.01) than the tissue of controls ( fi g. 4 ).
Expression of CCL24 mRNA in Cultured Cells
The basal expression of CCL24 mRNA in A-549 cell line was marginal near the detection limit. A representative result is shown in fi gure 5 . Proinfl ammatory cytokine TNF-␣ (10 ng/ml; lane 3), IFN-␥ (10 U/ml; lane 4), or IL-4 (10 ng/ml, lane 5) signifi cantly (p ! 0.05) enhanced the expression of CCL24 (6.6, 4.3 and 2.3%, respectively).
Costimulation with TNF-␣ and IFN-␥ (0.1 ng/ml and 10 U/ml or 10 ng/ml and 100 U/ml; lane 6 or 7, respectively) or TNF-␣ and IL-4 (0.1 and 1 ng/ml or 10 and 20 ng/ml; lane 9 or 10, respectively) revealed slightly synergistic effects enhancing the expression of CCL24 which was highest upon stimulation with 10-50 ng/ml TNF-␣ (mean 6-16.6% rel. density; fi g. 6 a). INF-␥ (1-300 U/ml) caused indifferent effects on CCL24 expression ranging from 0.9 to 13.4% (mean 3.2-5.1% rel. density; fi g. 6 b). IL-4 (1-50 ng/ml) caused minute enhancement of CCL24 mRNA expression ranging from 0.8 to 14.2% (mean 1.1-8.1% rel. density; fi g. 6 c).
Costimulation with increasing doses of TNF-␣ (0.1-30 ng/ml) and INF-␥ (3-300 U/ml) indifferently enhanced CCL24 mRNA expression from 0.9 to 16.8% (mean 2.3-11.7% rel. density). Increasing doses of costimulation with TNF-␣ (0.1-30 ng/ml) and IL-4 (1-30 ng/ml) tended towards a direct correlation of CCL24 mRNA expression (3.6-19.6%) without reaching statisti- cal signifi cance (p ! 0.1). The most prominent effects were observed for costimulation with high concentrations of TNF-␣ and INF-␥ (mean: 18.4-19.6% rel. density, p ! 0.05, compared to single exposure to TNF ␣ or IL-4; fi g. 6 e). Neither nasal fi broblasts of the inferior turbinates of controls nor fi broblasts of polypous tissue expressed detectable amounts of CCL24 mRNA (as expected from former experiments [15] , data not shown).
Synthesis of CCL24 in Cultured Cells
A-549 cells were cultured with proinfl ammatory cytokines TNF-␣ , IFN-␥ , or IL-4 ( fi g. 7 ). There was no welldefi ned dose response upon stimulation with IFN-␥ by itself ( fi g. 7 b). It has to be mentioned that there was a high variation in cellular CCL24 production ( fi g. 7 a-e).
TNF-␣ (0.1-50 ng/ml) induced moderate synthesis of CCL24 (0.01-0.37 ng/ml). Exposure to 3 ng/ml TNF-␣ CCl24 was induced at 0.15-0.45 ng/ml (mean 0.22-0.31 ng/ml, fi g. 7 e). The synthesis of CCL24 protein of nasal fi broblasts was not detected (data not shown).
Discussion
Immunoreactive CCL24 was observed in epithelial and endothelial cells of polypous tissue, whereas unaffected tissue of the inferior turbinate was negative. About 74% of polypous specimens expressed remarkable amounts of CCL24 mRNA (0.7-24.3% density of GAPDH) and CCL24 protein (mean 0.24 ng/mg). Cultured nasal fi broblasts did not express or synthesize CCL24, neither unstimulated nor upon stimulation with variable cytokines. In contrast, unstimulated epithelial cells expressed minute amounts of CCL24, which was (not well-defi ned) dose-dependently upregulated by the cytokines TNF-␣ , INF-␥ , and IL-4 (1.8-19.6%). The synthesis of CCL24 protein was induced by these proinfl ammatory cytokines (0.1-0.3 ng/ml) with TNF-␣ and IL-4 (0.2-0.3 ng/ml) showing synergistic effects.
CC chemokines attract and activate eosinophilic leukocytes to the site of infl ammation [11, 23] . In previous studies we extracted an eosinophilic chemotactic activity in nasal polyps [24] . Furthermore, the immunohistochemical results of the present study are in accordance with others demonstrating epithelial cells as the main source of CCL24 expression in nasal polyps [25] . In addition, CCL11 was immunohistochemically located in certain leukocytes as well as in human respiratory epithelium and in nasal polypous tissue, accompanied by an infi ltration of eosinophils at sites of CCL11 upregulation [26] . Polypous nasal tissue synthesized signifi cantly higher amounts of CCL11 and CCl24 than the middle turbinate [25] . CCL11 and CCL24 are most likely associated with Th2 immune response [27] . These fi ndings are in accordance with our immunohistochemical results. In previous experiments, we demonstrated a dose-and timedependent upregulation of CCL11 by proinfl ammatory cytokines [18] , which could not be demonstrated for the expression and production of CCL24 for cultured cells in the recent investigation.
Chronic polyposis in patients suffering from sinusitis is mostly accompanied by mucosal eosinophilia of mucosal airways. The number of activated eosinophils is signifi cantly higher in nasal polyps than in unaffected nasal tissue [10] . This points toward an impact of eosinophils and the importance of CC chemokines like CCL24, as shown in this study, although a further underlying chemotactic mechanism causing selective infi ltration of eosinophils remains unknown.
Based on our recent and previous fi ndings we conclude that the elevated mRNA expression and production of CCL24 protein, in association with additional/synergistic infl ammatory mediators (e.g. TNF-␣ , INF-␥ , and/or IL-4), points towards a prominent role of CCL24 as a relevant factor of persistent chronic infl ammation in the pathogenesis of chronic nasal polyps accompanied by eosinophilia.
This statement has to be evaluated carefully due to the relatively small number of samples investigated for each group. However, the role of CCL24 points towards CCL24 as being a pivotal factor underlying persistent chronic infl ammation like e.g. chronic polyposis. Further experiments were initiated and will have to prove the role of CCL24 and its natural receptor CCR-3 as a prominent factor in the pathogenesis of eosinophilia-associated infl ammatory nasal diseases, which might initiate the development of new therapeutics.
